{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:32:31Z","timestamp":1791639151630,"version":"4.3.4"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","funder":[{"name":"Vaincre la mucoviscidose","award":["N\u00c2\u00b0RC20220502992\/1\/1\/39"],"award-info":[{"award-number":["N\u00c2\u00b0RC20220502992\/1\/1\/39"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>Circulating extracellular vesicles (EVs) have shown promising results as noninvasive biomarkers for predicting disease outcomes in solid organ transplantation. Because in situ graft cell expression of the tolerogenic molecule HLA-G is associated with acceptance after lung transplantation (LTx), we hypothesized that plasma EV-bound HLA-G (HLA-G<jats:sub>EV<\/jats:sub>) levels could predict chronic lung allograft dysfunction (CLAD) development.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>We analyzed 78 LTx recipients from the Cohort-for-Lung-Transplantation cohort, all in a stable (STA) state within the first year post-LTx. At 3 y, 41 patients remained STA, and 37 had CLAD (bronchiolitis obliterans syndrome, BOS, [n\u2005=\u200532] or restrictive allograft syndrome [n\u2005=\u20055]). HLA-G<jats:sub>EV<\/jats:sub> plasma levels were measured at month 6 (M6) and M12 in 78 patients. CLAD occurrence and graft failure at 3 y post-LTx were assessed according to early HLA-G<jats:sub>EV<\/jats:sub> plasma levels.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>In patients with subsequent BOS, (1) HLA-G<jats:sub>EV<\/jats:sub> levels at M12 were significantly lower than those in STA patients (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.013) and (2) also significantly lower than their previous levels at M6 (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.04).<\/jats:p>\n            <jats:p>A lower incidence of CLAD and BOS and higher graft survival at 3 y were observed in patients with high HLA-G<jats:sub>EV<\/jats:sub> plasma levels at M12 (high versus low HLA-G<jats:sub>EVs<\/jats:sub> patients [cutoff 21.3\u2009ng\/mL]: freedom from CLAD, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.002; freedom from BOS, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005&lt;\u20050.001; and graft survival, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.04, [log-rank]). Furthermore, in multivariate analyses, low HLA-G<jats:sub>EV<\/jats:sub> levels at M12 were independently associated with a subsequent risk of CLAD, BOS, and graft failure at 3 y (<jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.015, <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.036, and <jats:italic toggle=\"yes\">P<\/jats:italic>\u2005=\u20050.026, respectively [Cox models]).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>This exploratory study suggests the potential of EV-bound HLA-G plasma levels as a liquid biopsy in predicting CLAD\/BOS onset and subsequent graft failure.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000005175","type":"journal-article","created":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T04:01:40Z","timestamp":1726718500000},"page":"736-745","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Circulating Vesicular-bound HLA-G as Noninvasive Predictive Biomarker of CLAD After Lung Transplantation"],"prefix":"10.1097","volume":"109","author":[{"given":"Olivier","family":"Brugi\u00e8re","sequence":"first","affiliation":[{"name":"Service de Pneumologie et Transplantation Pulmonaire, H\u00f4pital Foch, Suresnes, France."},{"name":"CEA, DRF-Institut de Biologie Francois Jacob, Service de Recherches en H\u00e9mato-Immunologie, H\u00f4pital Saint-Louis, Paris, France."},{"name":"U976 HIPI, IRSL, Universit\u00e9 Paris Cit\u00e9, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dora","family":"Dreyfuss","sequence":"additional","affiliation":[{"name":"CEA, DRF-Institut de Biologie Francois Jacob, Service de Recherches en H\u00e9mato-Immunologie, H\u00f4pital Saint-Louis, Paris, France."},{"name":"U976 HIPI, IRSL, Universit\u00e9 Paris Cit\u00e9, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Guilet","sequence":"additional","affiliation":[{"name":"CEA, DRF-Institut de Biologie Francois Jacob, Service de Recherches en H\u00e9mato-Immunologie, H\u00f4pital Saint-Louis, Paris, France."},{"name":"U976 HIPI, IRSL, Universit\u00e9 Paris Cit\u00e9, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Rong","sequence":"additional","affiliation":[{"name":"CEA, DRF-Institut de Biologie Francois Jacob, Service de Recherches en H\u00e9mato-Immunologie, H\u00f4pital Saint-Louis, Paris, France."},{"name":"U976 HIPI, IRSL, Universit\u00e9 Paris Cit\u00e9, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Hirschi","sequence":"additional","affiliation":[{"name":"Department of Pneumology, Strasbourg Lung Transplant Program, Strasbourg University Hospital, Strasbourg, France."},{"name":"INSERM UMR 1260, Regenerative Nanomedicine, University of Strasbourg, Strasbourg, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Renaud-Picard","sequence":"additional","affiliation":[{"name":"Department of Pneumology, Strasbourg Lung Transplant Program, Strasbourg University Hospital, Strasbourg, France."},{"name":"INSERM UMR 1260, Regenerative Nanomedicine, University of Strasbourg, Strasbourg, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Reynaud-Gaubert","sequence":"additional","affiliation":[{"name":"Service de Pneumologie et Transplantation Pulmonaire, CHU de Marseille, Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Coiffard","sequence":"additional","affiliation":[{"name":"Service de Pneumologie et Transplantation Pulmonaire, CHU de Marseille, Marseille, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Bunel","sequence":"additional","affiliation":[{"name":"APHP.Nord-Universit\u00e9 de Paris, H\u00f4pital Bichat-Claude Bernard, Service de Pneumologie B et Transplantation Pulmonaire, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Messika","sequence":"additional","affiliation":[{"name":"APHP.Nord-Universit\u00e9 de Paris, H\u00f4pital Bichat-Claude Bernard, Service de Pneumologie B et Transplantation Pulmonaire, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Demant","sequence":"additional","affiliation":[{"name":"Service de Pneumologie et Transplantation Pulmonaire, CHU de Bordeaux, Bordeaux, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Le Pavec","sequence":"additional","affiliation":[{"name":"Service de Pneumologie et Transplantation Pulmonaire, H\u00f4pital Marie-Lannelongue, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaelle","family":"Dauriat","sequence":"additional","affiliation":[{"name":"Service de Pneumologie et Transplantation Pulmonaire, H\u00f4pital Marie-Lannelongue, Le Plessis-Robinson, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christel","family":"Saint Raymond","sequence":"additional","affiliation":[{"name":"Service Hospitalier Universitaire de Pneumologie et Physiologie, P\u00f4le Thorax et Vaisseaux, CHU Grenoble Alpes, \u00c9chirolles, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loic","family":"Falque","sequence":"additional","affiliation":[{"name":"Service Hospitalier Universitaire de Pneumologie et Physiologie, P\u00f4le Thorax et Vaisseaux, CHU Grenoble Alpes, \u00c9chirolles, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Mornex","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Claude Bernard Lyon1, INRAE, IVPC, Lyon, France."},{"name":"Hospices Civils de Lyon, Inserm CIC1407, Bron, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrien","family":"Tissot","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, CHU Nantes, INSERM, Service de Pneumologie, l\u2019institut du thorax, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Lair","sequence":"additional","affiliation":[{"name":"Nantes Universit\u00e9, CHU Nantes, INSERM, Service de Pneumologie, l\u2019institut du thorax, Center for Research in Transplantation and Translational Immunology, UMR 1064, Nantes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelie","family":"Le Borgne Krams","sequence":"additional","affiliation":[{"name":"Service de Pneumologie et Transplantation Pulmonaire, CHU de Toulouse, Toulouse, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronique","family":"Bousseau","sequence":"additional","affiliation":[{"name":"Service de Pneumologie et Transplantation Pulmonaire, H\u00f4pital HEGP, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Magnan","sequence":"additional","affiliation":[{"name":"Service de Pneumologie et Transplantation Pulmonaire, H\u00f4pital Foch, Suresnes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cl\u00e9ment","family":"Picard","sequence":"additional","affiliation":[{"name":"Service de Pneumologie et Transplantation Pulmonaire, H\u00f4pital Foch, Suresnes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Roux","sequence":"additional","affiliation":[{"name":"Service de Pneumologie et Transplantation Pulmonaire, H\u00f4pital Foch, Suresnes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Glorion","sequence":"additional","affiliation":[{"name":"Service de Chirurgie thoracique, H\u00f4pital Foch, Suresnes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryvonick","family":"Carmagnat","sequence":"additional","affiliation":[{"name":"Service d\u2019 Immunologie et histocompatibilit\u00e9 HLA, H\u00f4pital Saint-Louis, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Gazeau","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, MSC et int\u00e9grateur IVETh, CNRS UMR7057, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Aubertin","sequence":"additional","affiliation":[{"name":"Universit\u00e9 Paris Cit\u00e9, MSC et int\u00e9grateur IVETh, CNRS UMR7057, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Carosella","sequence":"additional","affiliation":[{"name":"CEA, DRF-Institut de Biologie Francois Jacob, Service de Recherches en H\u00e9mato-Immunologie, H\u00f4pital Saint-Louis, Paris, France."},{"name":"U976 HIPI, IRSL, Universit\u00e9 Paris Cit\u00e9, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Vall\u00e9e","sequence":"additional","affiliation":[{"name":"Service d\u2019\u00e9pid\u00e9miologie et sant\u00e9 publique, H\u00f4pital Foch, Suresnes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Landais","sequence":"additional","affiliation":[{"name":"Departement de biostatistiques, DRCI H\u00f4pital Foch, Suresnes, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Rouas-Freiss","sequence":"additional","affiliation":[{"name":"CEA, DRF-Institut de Biologie Francois Jacob, Service de Recherches en H\u00e9mato-Immunologie, H\u00f4pital Saint-Louis, Paris, France."},{"name":"U976 HIPI, IRSL, Universit\u00e9 Paris Cit\u00e9, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel","family":"LeMaoult","sequence":"additional","affiliation":[{"name":"CEA, DRF-Institut de Biologie Francois Jacob, Service de Recherches en H\u00e9mato-Immunologie, H\u00f4pital Saint-Louis, Paris, France."},{"name":"U976 HIPI, IRSL, Universit\u00e9 Paris Cit\u00e9, Paris, France."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the COLT Consortium","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,9,19]]},"reference":[{"key":"R1-20250325","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1164\/rccm.201101-0134CI","article-title":"Lung transplantation.","volume":"184","author":"Kotloff","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"R2-20250325","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment\u2014a consensus report from the Pulmonary Council of the ISHLT.","volume":"38","author":"Verleden","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R3-20250325","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.healun.2019.03.008","article-title":"Chronic lung allograft dysfunction: definition and update of restrictive allograft syndrome\u2014a consensus report from the Pulmonary Council of the ISHLT.","volume":"38","author":"Glanville","year":"2019","journal-title":"J Heart Lung Transplant"},{"key":"R4-20250325","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.healun.2017.07.016","article-title":"The Registry of the International Society for Heart and Lung Transplantation: thirty-fourth adult lung and heart-lung transplantation report-2017; focus theme: allograft ischemic time.","volume":"36","author":"Chambers","year":"2017","journal-title":"J Heart Lung Transplant"},{"key":"R5-20250325","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1681\/ASN.2007020180","article-title":"Frontiers in nephrology: immune tolerance to allografts in humans.","volume":"18","author":"Girlanda","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R6-20250325","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/bs.ai.2015.04.001","article-title":"HLA-G: an immune checkpoint molecule.","volume":"127","author":"Carosella","year":"2015","journal-title":"Adv Immunol"},{"key":"R7-20250325","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/tan.12053","article-title":"HLA-G 2012 conference: the 15-year milestone update.","volume":"81","author":"Loustau","year":"2013","journal-title":"Tissue Antigens"},{"key":"R8-20250325","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.healun.2022.03.004","article-title":"HLA-G\/ILT2 signaling on the path to tolerance.","volume":"41","author":"Wang","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R9-20250325","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.healun.2008.02.004","article-title":"Myocardial HLA-G reliably indicates a low risk of acute cellular rejection in heart transplant recipients.","volume":"27","author":"Sheshgiri","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"R10-20250325","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.humimm.2003.08.356","article-title":"Detection of HLA-G in serum and graft biopsy associated with fewer acute rejections following combined liver-kidney transplantation: possible implications for monitoring patients.","volume":"64","author":"Creput","year":"2003","journal-title":"Hum Immunol"},{"key":"R11-20250325","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1600-6143.2009.02650.x","article-title":"Immunohistochemical study of HLA-G expression in lung transplant recipients.","volume":"9","author":"Brugiere","year":"2009","journal-title":"Am J Transplant"},{"key":"R12-20250325","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/ajt.12977","article-title":"Role of HLA-G as a predictive marker of low risk of chronic rejection in lung transplant recipients: a clinical prospective study.","volume":"15","author":"Brugiere","year":"2015","journal-title":"Am J Transplant"},{"key":"R13-20250325","doi-asserted-by":"crossref","first-page":"e103643","DOI":"10.1371\/journal.pone.0103643","article-title":"Association of soluble HLA-G with acute rejection episodes and early development of bronchiolitis obliterans in lung transplantation.","volume":"9","author":"White","year":"2014","journal-title":"PLoS One"},{"key":"R14-20250325","doi-asserted-by":"crossref","first-page":"1802126","DOI":"10.1183\/13993003.02126-2018","article-title":"Donor human leukocyte antigen-G single nucleotide polymorphisms are associated with post-lung transplant mortality.","volume":"54","author":"Lazarte","year":"2019","journal-title":"Eur Respir J"},{"key":"R15-20250325","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1111\/ajt.13305","article-title":"HLA-G*01:04 approximately UTR3 recipient correlates with lower survival and higher frequency of chronic rejection after lung transplantation.","volume":"15","author":"Di Cristofaro","year":"2015","journal-title":"Am J Transplant"},{"key":"R16-20250325","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.tcb.2016.11.003","article-title":"Extracellular vesicles: unique intercellular delivery vehicles.","volume":"27","author":"Maas","year":"2017","journal-title":"Trends Cell Biol"},{"key":"R17-20250325","doi-asserted-by":"crossref","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","article-title":"Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines.","volume":"7","author":"Thery","year":"2018","journal-title":"J Extracell Vesicles"},{"key":"R18-20250325","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.healun.2020.06.011","article-title":"Circulating extracellular vesicles as non-invasive biomarker of rejection in heart transplant.","volume":"39","author":"Castellani","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R19-20250325","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/ajt.13915","article-title":"Donor-derived exosomes with lung self-antigens in human lung allograft rejection.","volume":"17","author":"Gunasekaran","year":"2017","journal-title":"Am J Transplant"},{"key":"R20-20250325","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.healun.2020.07.001","article-title":"Circulating exosomes with lung self-antigens as a biomarker for chronic lung allograft dysfunction: a retrospective analysis.","volume":"39","author":"Sharma","year":"2020","journal-title":"J Heart Lung Transplant"},{"key":"R21-20250325","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1164\/rccm.201503-0558OC","article-title":"Altered exosomal RNA profiles in bronchoalveolar lavage from lung transplants with acute rejection.","volume":"192","author":"Gregson","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"R22-20250325","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1097\/TP.0000000000000881","article-title":"Epithelial and erythrocyte microvesicles from bronchoalveolar lavage fluid are elevated and associated with outcome in chronic lung allograft dysfunction.","volume":"99","author":"Harms","year":"2015","journal-title":"Transplantation"},{"key":"R23-20250325","doi-asserted-by":"crossref","first-page":"104063","DOI":"10.1016\/j.cellimm.2020.104063","article-title":"Extracellular vesicles in allograft rejection and tolerance.","volume":"349","author":"Benichou","year":"2020","journal-title":"Cell Immunol"},{"key":"R24-20250325","first-page":"374","article-title":"Extracellular vesicles in transplantation: friend or foe.","volume":"108","author":"Bansal","year":"2024","journal-title":"Transplantation"},{"key":"R25-20250325","doi-asserted-by":"crossref","first-page":"121722","DOI":"10.1016\/j.lfs.2023.121722","article-title":"Exosomes in transplantation: role in allograft rejection, diagnostic biomarker, and therapeutic potential.","volume":"324","author":"Saravanan","year":"2023","journal-title":"Life Sci"},{"key":"R26-20250325","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.humimm.2003.08.344","article-title":"Exosomes bearing HLA-G are released by melanoma cells.","volume":"64","author":"Riteau","year":"2003","journal-title":"Hum Immunol"},{"key":"R27-20250325","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.humimm.2016.01.002","article-title":"The prognostic impact of soluble and vesicular HLA-G and its relationship to circulating tumor cells in neoadjuvant treated breast cancer patients.","volume":"77","author":"Konig","year":"2016","journal-title":"Hum Immunol"},{"key":"R28-20250325","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.3390\/cancers11081106","article-title":"Vesicular-bound HLA-G as a predictive marker for disease progression in epithelial ovarian cancer.","volume":"11","author":"Schwich","year":"2019","journal-title":"Cancers (Basel)"},{"key":"R29-20250325","doi-asserted-by":"crossref","first-page":"791535","DOI":"10.3389\/fimmu.2021.791535","article-title":"HLA-G\/sHLA-G and HLA-G-bearing extracellular vesicles in cancers: potential role as biomarkers.","volume":"12","author":"Li","year":"2021","journal-title":"Front Immunol"},{"key":"R30-20250325","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.3389\/fimmu.2020.02046","article-title":"Soluble HLA-G and HLA-G bearing extracellular vesicles affect ILT-2 positive and ILT-2 negative CD8 T cells complementary.","volume":"11","author":"Schwich","year":"2020","journal-title":"Front Immunol"},{"key":"R31-20250325","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3389\/fimmu.2016.00173","article-title":"The potential of HLA-G-bearing extracellular vesicles as a future element in HLA-G immune biology.","volume":"7","author":"Rebmann","year":"2016","journal-title":"Front Immunol"},{"key":"R32-20250325","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1186\/s12885-015-2025-z","article-title":"Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation.","volume":"15","author":"Grange","year":"2015","journal-title":"BMC Cancer"},{"key":"R33-20250325","doi-asserted-by":"crossref","first-page":"1795364","DOI":"10.1080\/20013078.2020.1795364","article-title":"Study of immune-tolerized cell lines and extracellular vesicles inductive environment promoting continuous expression and secretion of HLA-G from semiallograft immune tolerance during pregnancy.","volume":"9","author":"Cho","year":"2020","journal-title":"J Extracell Vesicles"},{"key":"R34-20250325","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.healun.2007.10.017","article-title":"Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection.","volume":"26","author":"Stewart","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"R35-20250325","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1016\/j.healun.2011.05.009","article-title":"Timing of basiliximab induction and development of acute rejection in lung transplant patients.","volume":"30","author":"Swarup","year":"2011","journal-title":"J Heart Lung Transplant"},{"key":"R36-20250325","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.healun.2022.01.013","article-title":"Chronic lung allograft dysfunction is associated with an early increase of circulating cytotoxic CD4+CD57+ILT2+ T cells, selectively inhibited by the immune check-point HLA-G.","volume":"41","author":"Brugiere","year":"2022","journal-title":"J Heart Lung Transplant"},{"key":"R37-20250325","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1183\/09031936.00107514","article-title":"An international ISHLT\/ATS\/ERS clinical practice guideline: Diagnosis and management of bronchiolitis obliterans syndrome.","volume":"44","author":"Meyer","year":"2014","journal-title":"Eur Respir J"},{"key":"R38-20250325","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1038\/leu.2014.41","article-title":"MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease.","volume":"28","author":"Kordelas","year":"2014","journal-title":"Leukemia"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005175","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T08:25:56Z","timestamp":1743150356000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/TP.0000000000005175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,19]]},"references-count":38,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000005175","relation":{},"ISSN":["0041-1337","1534-6080"],"issn-type":[{"value":"0041-1337","type":"print"},{"value":"1534-6080","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,9,19]]}}}